Literature DB >> 9760568

Mechanisms of peripheral T cell tolerance.

L van Parijs1, V L Perez, A K Abbas.   

Abstract

Peripheral tolerance to self proteins is induced because these antigens are presented to T lymphocytes under conditions that do not allow effective immune responses to develop, or because the responses of the specific T cells are tightly regulated. The two principal mechanisms of peripheral tolerance are activation-induced cell death (AICD) and anergy. In CD4+ T lymphocytes, AICD is induced by repeated stimulation, with high levels of interleukin (IL)-2 production. Under these conditions, the T cells co-express Fas (CD95) and Fas ligand (FasL), and engagement of Fas triggers apoptotic death of the T cells. Mice with defects in Fas, FasL, IL-2R alpha or beta chain exhibit defects in AICD and develop autoimmune disease. The induction of T cell anergy is dependent on the recognition of B7 co-stimulators by the inhibitory T cell counter-receptor, CTLA-4. Failure of anergy is the likely basis for the fatal autoimmune disease of CTLA-4 knockout mice. The single-gene defects that result in autoimmunity are all defects in lymphocyte regulation, indicating that tolerance is often maintained by the control of lymphocyte responses to self antigen. The existence of distinct pathways of T cell tolerance suggest that different types of antigens induce tolerance by distinct mechanisms.

Entities:  

Mesh:

Year:  1998        PMID: 9760568     DOI: 10.1002/9780470515525.ch2

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  9 in total

Review 1.  Controlling mature CD4+ T cell responses.

Authors:  M E Ozaki; S R Webb
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis.

Authors:  J W Zhu; S J Field; L Gore; M Thompson; H Yang; Y Fujiwara; R D Cardiff; M Greenberg; S H Orkin; J DeGregori
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  Abscopal regression of antigen disparate tumors by antigen cascade after systemic tumor vaccination in combination with local tumor radiation.

Authors:  James W Hodge; Hadley J Sharp; Sofia R Gameiro
Journal:  Cancer Biother Radiopharm       Date:  2012-01-27       Impact factor: 3.099

4.  Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells.

Authors:  Maria-Luisa del Rio; Carlos Fernandez-Renedo; Olivier Chaloin; Stefanie Scheu; Klaus Pfeffer; Yasushi Shintani; Jose-Antonio Perez-Simon; Pascal Schneider; Jose-Ignacio Rodriguez-Barbosa
Journal:  MAbs       Date:  2016-01-11       Impact factor: 5.857

5.  Effect of oestrogen on T cell apoptosis in patients with systemic lupus erythematosus.

Authors:  W-U Kim; S-Y Min; S-H Hwang; S-A Yoo; K-J Kim; C-S Cho
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 6.  Update on the immunological pathway of negative regulation in acute insults and sepsis.

Authors:  Ying-yi Luan; Yong-ming Yao; Zhi-yong Sheng
Journal:  J Interferon Cytokine Res       Date:  2012-04-17       Impact factor: 2.607

Review 7.  In vitro immunogenicity of undifferentiated pluripotent stem cells (PSC) and derived lineages.

Authors:  Suzanne Kadereit; Alan Trounson
Journal:  Semin Immunopathol       Date:  2011-04-05       Impact factor: 9.623

Review 8.  Overlooked Mechanisms in Type 1 Diabetes Etiology: How Unique Costimulatory Molecules Contribute to Diabetogenesis.

Authors:  David H Wagner
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-23       Impact factor: 5.555

9.  CD28 costimulation is required for in vivo induction of peripheral tolerance in CD8 T cells.

Authors:  Melanie S Vacchio; Richard J Hodes
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.